<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314694/" ref="ordinalpos=1376&amp;ncbi_uid=3882308&amp;link_uid=PMC3314694" image-link="/pmc/articles/PMC3314694/figure/pone-0033976-g001/" class="imagepopup">Figure 1. Expression of Wnt <span class="highlight" style="background-color:">pathway</span> genes in tumorspheres (TMS), mammospheres (MMS) and mammospheres induced to differentiate (diffMMS)..  From: Small Molecule Antagonists of the Wnt/Beta-Catenin <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span> Target Breast Tumor-Initiating Cells in a Her2/Neu Mouse Model of Breast Cancer. </a></div><br /><div class="p4l_captionBody">A) Heat maps of 3 independent TMS (A, n = 3), MMS (B, n = 3) and diffMMS (C, n = 3) RNA preparations profiled on MOE430A Gene Chips. B–E) qRT-PCR of transcripts encoding components and target genes of the Wnt signaling pathway (* p&lt;0.05, t-test) for all genes shown. F and G) Survival, (*p = 0.005, Log-rank test) and metastasis (*p = 0.0068, Log-rank test), curves for human breast cancer patients classified based on their expression of TMS-related and TMS-unrelated (diffMMS-related) specific Wnt pathway components.</div></div>